Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Health products
Remove filter for
Issue: Product safety
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 623 items.
Importation of Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules due to the Current Shortage of Canadian-authorized Cisatracurium Omega
AlertHealth professional risk communication | 2024-04-24
Miracle Reds: missing risk statement
RecallHealth product recall | 2024-04-23
JAMP-Guanfacine XR 4 mg: Foreign matter
RecallHealth product recall | 2024-04-10
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions
AlertHealth professional risk communication | 2024-03-27
Paclitaxel-Coated Balloons (PCB) and Paclitaxel-Eluting Stents (PES) for the Treatment of Peripheral Arterial Disease (PAD) and the Potential Risk of Long-Term All-Cause Mortality
AlertHealth professional risk communication | 2024-02-20
VitalBulk : Product contains level of nicotinic acid found in prescription drugs
RecallHealth product recall | 2024-02-09
JAMP Guanfacine XR 1 mg: Foreign tablets
RecallHealth product recall | 2023-12-14
Donepezil 10 mg tablets: Affected lot may contain over-sized tablets
RecallHealth product recall | 2023-11-27
Herbaland brand gummy vitamins and supplements: Inadequate product labelling
RecallHealth product recall | 2023-11-14
Herbaland brand gummy vitamins and supplements: Inadequate product labelling
RecallHealth product recall | 2023-11-14
Importation of UK-Authorized Potassium Chloride 15% w/v Concentrate for Solution for Infusion due to shortage of Canadian-authorized Potassium Chloride for Injection Concentrate
AlertHealth professional risk communication | 2023-10-24
Baxter Intravenous Solution Bags – Potential Leak During Spiking of Administration Port
AlertHealth professional risk communication | 2023-10-06
APO-AMITRIPTYLINE 10mg: NDMA Impurity
RecallHealth product recall | 2023-02-07
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance to specific SARS-CoV-2 Subvariants
AlertHealth professional risk communication | 2023-01-17
COMIRNATY Original & Omicron BA.4/BA.5 Bivalent Vaccine with English-only Vial and Carton Labels: New Formulation for Use in Children 5 to Less Than 12 Years of Age
AlertHealth professional risk communication | 2022-12-09